Clinical Aspect and Treatment of Intracranial Mycotic Aneurysm / 감염과화학요법
Infection and Chemotherapy
; : 369-374, 2010.
Article
in Ko
| WPRIM
| ID: wpr-11011
Responsible library:
WPRO
ABSTRACT
Intracranial mycotic aneurysm (IMA) is rare, but life-threatening cerebrovascular lesion, which arises from a variety of primary infection foci such as infective endocarditis, bacterial meningitis, cavernous sinus thrombophlebitis, etc. The diagnosis of IMA usually depends on the documentation of an intracranial aneurysm by vascular imaging in the presence of primary infection foci. As the gold standard for detecting IMA, high-tech computed tomography will eventually replace cerebral angiography. Because of the lack of prospective cohorts and randomized controlled trials, there is no widely accepted treatment guideline for IMA. With recent advances in surgical technique and the introduction of endovascular therapy, however, clinical outcome of patients with IMA tends to improve. This review will provide the state-of-the-art knowledge on clinical aspect and treatment strategy of IMA.
Key words
Full text:
1
Index:
WPRIM
Main subject:
Cerebral Angiography
/
Intracranial Aneurysm
/
Cohort Studies
/
Meningitis, Bacterial
/
Cavernous Sinus Thrombosis
/
Endocarditis
Type of study:
Clinical_trials
/
Etiology_studies
/
Guideline
/
Incidence_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Humans
Language:
Ko
Journal:
Infection and Chemotherapy
Year:
2010
Type:
Article